The protein kinase 
associated with Thrl60 phosphorylated active CDK2. In pRBcells, however, p21 was bound preferentially to the unphosphorylated, inactive form of CDK2 even though the phosphorylated form was abundant. This is the first evidence suggesting that G1 arrest by 4 nM staurosporine is dependent on a functional pRB protein. Cell cycle arrest at the pRBdependent checkpoint may prevent activation of cyclin E/CDK2 by stabilizing its interaction with inhibitor proteins p21 and p27.
The protein kinase inhibitor staurosporine induces both G1 and G2 arrests in normal cells but only G2 arrest in most transformed cells (1) (2) (3) . Two temporally distinct staurosporine arrest points have been identified in the GI phase of normal human diploid fibroblasts that are induced by either [1] [2] [3] [4] nM or 20 nM staurosporine (4) . At both arrest points, the retinoblastoma protein (pRB) is hypophosphorylated and total cyclin-dependent kinase (CDK) 2 activity is reduced. G1 arrest was not observed in several virus-transformed tumor cell lines treated with staurosporine, which suggests that the pathway leading to G1 arrest by staurosporine is deregulated in these cells (3) (4) (5) . One of the proteins that is a target for viral oncoproteins such as simian virus 40 large T antigen is pRB (6) , suggesting that pRB could be responsible for G1 arrest by staurosporine. Microinjection of pRB leads to G1 arrest in pRB-lacking cells (7) . Probably hypophosphorylated pRB
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controls the activity of transcription factors such as those of the E2F family that are required for further cell cycle progression (for review, see ref. 8 ).
The functional state of pRB during the cell cycle is presumably regulated by Ser/Thr phosphorylations at multiple sites. A peak in active hypophosphorylated pRB is observed at early to mid G1 (9) (10) (11) . Hyperphosphorylated and, presumably, inactive pRB appear around the G1/S transition and persist until completion of mitosis. The protein kinases most likely responsible for pRB phosphorylation are the cell cycleregulated CDK4, CDK6, and CDK2 (12) (13) (14) . These CDKs are themselves regulated by phosphorylation and by several protein inhibitors (for reviews, see refs. [15] [16] [17] . The deregulation of CDK4 and CDK2 in virus-transformed and other tumor cells further stresses the importance of pRB in the maintenance of cell cycle control (18) . The introduction of pRBexpressing vectors into a variety of pRB-cells suppresses their tumorigenicity in nude mice, but no consistent growth phenotypes have differentiated between pRB+ and pRB-cells (19) (20) (21) (22) (23) (24) . However, cell cycle arrest induced by depletion of cyclin D1 or inactivation of CDK4 by the CDK4 inhibitor p16 requires pRB (25) (26) (27) (28) . This (29) .
Immunoblot. Cells were lysed by sonication twice for 10 s in CDK4-immunoprecipitation (IP) buffer as described (12) Kinase assays were carried out as described (12) except that for the majority of CDK4 assays 0.5 ,tg of p56-RB per 30 t,l was used as a substrate rather than GST-RB. The final ATP concentrations were 1 mM CDK2,0.5 mM cyclin E-CDK2, and 20 ,tM cyclin D1-CDK4. The assay time was 15 min for CDK2 and 30 min for cyclin E-CDK2 and CDK4. All assays were done at 30°C. The reactions were stopped by the addition of 6 tpl of SDS sample buffer. The total reaction mix was applied on a gel. Gels were stained with Coomassie blue, destained, and dried.
The bands were visualized by autoradiography and cut out for quantitation in a scintillation counter. All assays were performed at least twice.
RESULTS
Staurosporine Induces G1 Arrest in pRB+ Cells. The bladder carcinoma cell line 5637 lacks pRB and induces tumors in nude mice. When 5637 cells were infected with a pRBexpressing retrovirus, the tumorigenicity of these cells was reduced (19) . We compared the responses of pRB-5637 and the pRB+ clone 5637-RB-5 with the protein kinase inhibitor staurosporine. We have shown previously that treatment with 2-4 nM staurosporine for 24 hr induces cell cycle arrest in GI phase (4) . With the same treatment, GI arrest was not observed in 5637 cells lacking pRB. However, pRB+ cells undergo cell cycle arrest, with an almost complete disappearance of S phase cells in response to 4 nM staurosporine (Fig. 1A) . It (Fig. 1B) . As expected, we were unable to detect any pRB in 5637 cells. In contrast, 5637-RB-5 cells containing the pRB cDNA expressed both hypo-and hyperphosphorylated pRB. However, in staurosporine-treated 5637-RB-5 cells, pRB accumulated in its hypophosphorylated form, which is characteristic of pRB expressing G1 cells. These results suggest that pRB is required for the G1 arrest induced by 4 nM staurosporine in the bladder carcinoma cell line 5637.
Cyclin D1-CDK4/CDK6 Activity Is Reduced in Staurosporine-Treated pRB+ and pRB-Cells. Because both CDK4 and CDK6 can phosphorylate pRB (12, 13) , their activity was determined after 4 nM staurosporine treatment. We analyzed the CDK4/CDK6 kinase activities associated with cyclin D1, but not cyclins D2 and D3, because cyclin D1 has been reported to be essential for GI phase progression in cells with a functional pRB (25) . Cyclin Dl/CDK4/CDK6 from asynchronously growing cells and from staurosporine-treated cells were immunoprecipitated and the kinase activities were determined using p56-RB as a substrate (Fig. 2, lanes 3-6) GI phase, resulting in a relatively higher cyclin D1/CDK4/CDK6 activity in these cells. To determine the cyclin D1/CDK4/CDK6 activity in early-to-mid G1 phase, 5637 cells were synchronized with nocodazole in mitosis and released into a drug-free medium. Samples were taken at 3 and 6 hr after release and cyclin D1 IP was performed followed by kinase assays (Fig. 2, lanes 1 and 2) . Compared with asynchronously growing 5637 cells, the cyclin D1/CDK4/CDK6 activity in synchronized cells was about 3-fold higher. This would imply that in pRB+ cells the cyclin D1/CDK4/CDK6 activity is most probably reduced to about 20% by treatment with 4 nM staurosporine for 24 hr.
When CDK4 and cyclin Dl proteins were analyzed by immunoblotting, the levels of both proteins were largely unaffected by staurosporine treatment (Fig. 2B) (34) . We tested cyclin E/CDK2 and total CDK2 activities, using histone H1 as a substrate, in staurosporinetreated pRB-and pRB+ cells (Fig. 3) . In pRB+ cells, staurosporine treatment resulted in a 70% reduction in the cyclin E/CDK2 activity (Fig. 3A) . In There are at present three inhibitor proteins, p2(wafl/cipl), p27(Kipl), and p57(Kip2) known to bind and inhibit CDK2.
Whereas p21 and p27 expression seems to be ubiquitous, p57 expression is tissue specific and related to terminally differentiated cells (37) (38) (39) (40) (41) (42) (43) . Therefore, we examined the effect of staurosporine on p21 and p27 expression and their association with CDK complexes. Immunoblot analysis showed that p21 accumulated in staurosporine-treated pRB-cells and, to a much lesser extent, in staurosporine-treated pRB+ cells (Fig.  4A) . It is known that p21 is induced by y-irradiation in the presence of wild-type p53 protein (44) . However, the increase that we observed here is likely to be independent of p53, because both cell lines express stable p53 proteins characteristic of mutant forms (data not shown). To estimate the amount of p21 that is associated with CDK2, we performed IP experiments with anti-CDK2 antibodies followed by immunoblot analyses with anti-CDK2 and anti-p21 antibodies (Fig.  4B) . We detected little or no p21 associated with CDK2 in untreated pRB-cells as compared with pRB+ cells. On staurosporine treatment, there was a 2-fold increase in p21 coprecipitated with CDK2 in pRB+ cells and a 2-to 3-fold increase in pRB-cells (Table 1) . However, the amount of p21 bound to CDK2 in staurosporine-treated pRB-cells was 2-to 3-fold lower than in staurosporine-treated pRB+ cells. A similar difference in the ratio of p21 to CDK2 was also confirmed by p21 IP and cyclin E IP from staurosporinetreated cells (Table 1) . To determine which form of CDK2, Thrl60 phosphorylated or unphosphorylated, was associated with p21 in staurosporine-treated cells, we performed IP with anti-p21 and immunoblotted for CDK2, CDK4, and p21 (Fig.  4C) . About equal amounts of p21 from both cell lines was immunoprecipitated. In pRB-cells, p21 associated equally well with both forms of CDK2. In contrast, in pRB+ cells the active Thrl60 phosphorylated form of CDK2 was predominant in coprecipitates with p21. As expected, there was less CDK2 coprecipitated with p21 in pRB+ as compared with pRB-cells. CDK4 was also present in coprecipitates with p21. But, in comparison with CDK2, the amount of CDK4 was nearly equal in pRB-and pRB' cells. This confirmed that there was more p21 associated per CDK2 in pRB+ as compared with pRBcells. The stoichiometry of p21/CDK2 complexes has been shown to be important in determining kinase activity. While a 1:1 or lower ratio of p21 to CDK2 does not inhibit CDK2 a higher 2:1 ratio is effective in inhibiting CDK2 activity (45) . In pRB+ cells, at least a 2-fold increase in p21 associated with CDK2 was observed while the amount of p21 associated with CDK2 in staurosporine-treated pRB-cells was less than in untreated pRB+ cells. Our results show that the amount of p21 that associated with CDK2 in staurosporine-treated pRBcells was probably not sufficient to inhibit CDK2 activity.
We also analyzed the level of p27(KiPl) by immunoblot. The level of p27 increased on staurosporine treatment in both pRB-and pRB+ cells (Fig. 5A) . We further analyzed the association of p27 with CDK2 by immunoblotting for CDK2 after IP with anti-p27 antibodies (Fig. 5B) . In untreated pRBcells, there was no detectable p27 associated with CDK2, whereas in untreated pRB+ cells CDK2 was associated with p27. The amount varied depending on the culture batch. On . 
DISCUSSION
It has been shown that the kinase inhibitor staurosporine arrests normal cells in both G1 and G2 phases of the cell cycle (1-3). However, virus-transformed mammalian cells are resistant to G1 arrest but not G2 arrest by staurosporine (3, 5) . One of the effects of a viral oncogene such as simian virus 40 T antigen is the inactivation of pRB protein (6) . The (35) , and the binding of inhibitor proteins p21, p27, and p57 (37) (38) (39) (40) (41) (42) . The level of cyclin E and its association with CDK2 in pRB-and pRB+ cells was analyzed and found to be unchanged on staurosporine treatment. We also analyzed Thrl60 phosphorylation, which activates CDK2. Previously, we found that staurosporine caused the accumulation of Thrl60 unphosphorylated CDK2 in normal diploid fibroblasts (4). Here we also observed a higher ratio of unphosphorylated to phosphorylated CDK2, but this was independent of the presence of pRB. This suggested an involvement of inhibitor proteins in CDK2 inactivation by staurosporine. We analyzed p21 and p27 protein levels and their association with CDK2 in pRB-and pRB+ cells. p21 levels increased on staurosporine treatment of both pRB+ and pRB-cells. In exponentially growing pRB+ cells, the ratio of p21 to CDK2 was 3-to 4-fold higher than in pRB-cells and increased further on staurosporine treatment. In pRB-cells, although the level of p21 increased, the p21 to CDK2 ratio remained always 2-to 3-fold lower compared with pRB+ cells. Probably a drastic exogenous overexpression of p21 may partly or completely inhibit CDK2 in pRB-cells as well because exogenously produced p21 caused slow growth in other cell lines with functionally inactive pRB (38) . We also found an increase of p27 by staurosporine in both pRB-and pRB+ cells. As in the case of p21, our data suggest that there is more p27 associated with CDK2 in pRB+ cells than in pRB-cells resulting in CDK2 inhibition. Therefore, it seems that the p21 and p27 to CDK2 complex formations do not occur efficiently in pRB-cells. It was reported that a simian virus 40 T antigen transformed cell line contained altered CDK2 complex compared with normal fibroblasts. Instead of p21 other proteins were found to associate with CDK2 (18, 47) . It is tempting to speculate that in pRB-cells, CDK2 associates with a protein that is not inhibitory, but occupies the same site on CDK2 as p21 and p27. Thus, in staurosporine-treated pRB-cells, instead of two molecules of p21 that are necessary for CDK2 inhibition, only one molecule of p21 may bind to CDK2. Possibly pRB regulates the level of CDK2-associated proteins and thereby influences the composition and activity of CDK2 complexes. pRB may negatively regulate the level of a p21 or p27 competitor protein for CDK2, thus allowing more p21 and p27 to bind to CDK2.
